Alembic Pharmaceuticals

Alembic Pharmaceuticals
Alembic Pharmaceuticals
Shareholder Return: 3-year, Sales Growth: 3-year CAGR, Return On Equity: 3-year average
At a Glance
  • Shareholder Return
    128%
  • Sales Growth
    19%
  • Return on Equity
    39 %

Why Super 50

The 109-year-old, Vadodara-based company, promoted by the Amin family, is one of the oldest pharma entities in the country. The current generation-led by Pranav and Shaunak Amin-have transformed the enterprise into a modern maker of generic drugs, with a significant presence in the US market through its own front-end. The success is also a result of operational improvements, such as beefing up of supply chains and human resources.



More Stories